Known targets — ChEMBL curated mechanism
PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Phenylalanine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.71 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.71 |
| ▸ | ALPI | P09923 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | XIAP | P98170 | 1/20 | 0.71 |
| ▸ | GSR | P00390 | 1/20 | 0.65 |
| ▸ | MMP2 | P08253 | 2/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 1/20 | 0.49 |
| ▸ | MC5R | P33032 | 1/20 | 0.49 |
| ▸ | MC3R | P41968 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL28456803 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL8215749 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL1537423 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL237820 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL8220086 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL20740839 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL3220238 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL21314200 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL20740843 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL27622242 | 1.00 | SLC7A5 (0.71) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4028 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151890-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-07-18 | — | — | WO | claimed |
| US-20240238440-A1 | PREPARATION METHOD FOR AND APPLICATION OF ANTIBODY CONJUGATED DRUG | HYSLINK THERAPEUTICS (CN) | 2024-07-18 | — | — | US | claimed |
| WO-2024149345-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-07-18 | — | — | WO | claimed |
| US-20240238431-A1 | Bispecific Antibody-Drug Conjugate | BEIJING XUANZHU COMBIO CO., LTD. (CN) | 2024-07-18 | — | — | US | claimed |
| WO-2024140917-A1 | ANTI-CD40 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 上海盛迪医药有限公司 | 2024-07-04 | — | — | WO | claimed |
| US-20240207418-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. | 2024-06-27 | — | — | US | claimed |
| US-20240207429-A1 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-06-27 | — | — | US | claimed |
| WO-2024129614-A1 | SOMATOSTATIN SUBTYPE-2 RECEPTOR (SST2R) TARGETED THERAPEUTICS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. (US) | 2024-06-20 | — | — | WO | claimed |
| US-20240189430-A1 | EXTRACELLULAR VESICLE LINKED TO A BIOLOGICALLY ACTIVE MOLECULE VIA AN OPTIMIZED LINKER AND AN ANCHORING MOIETY | LONZA SALES AG (CH) | 2024-06-13 | — | — | US | claimed |
| CN-118141945-A | HER2 nanobody drug conjugates | 香港城市大学深圳福田研究院 | 2024-06-07 | — | — | CN | claimed |
| EP-0941120-A1 | BRANCHED PEPTIDE LINKERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-09-15 | — | — | EP | claimed |
| EP-0877628-A2 | BUFFER SYSTEMS FOR USE IN STABILIZING PHARMACEUTICAL PREPARATIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-11-18 | — | — | EP | claimed |
| WO-1998019705-A1 | BRANCHED PEPTIDE LINKERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-14 | — | — | WO | claimed |
| WO-1997028104-A2 | BUFFER SYSTEMS FOR USE IN STABILIZING PHARMACEUTICAL PREPARATIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-08-07 | — | — | WO | claimed |
| WO-1997000893-A1 | INTERLEUKIN-8 RECEPTOR BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1997-01-09 | — | — | WO | claimed |
| EP-0624377-A2 | Lysosomal enzyme-cleavable antitumor drug conjugates | Bristol-Myers Squibb Company (US) | 1994-11-17 | — | — | EP | claimed |
| US-4835258-A | Conjugation of aromatic amines or nitro-containing compounds with proteins or polypeptides by photoirradiation of the azide derivatives with ultraviolet light in order to produce antibodies against the haptens | NORTHWESTSERN UNIVERSITY (US) | 1989-05-30 | — | — | US | claimed |
| EP-0134307-B1 | PREACTIVATED SURFACES OF SYNTHETIC MATERIALS FOR IMMOBILIZING ORGANOCHEMICAL AND BIOLOGICAL SUBSTANCES, PROCESS FOR PREPARING THEM AND THEIR USE | Henning Berlin GmbH Chemie und Pharmawerk (DE) | 1989-04-19 | — | — | EP | claimed |
| US-4376766-A | Anti-sickling agents | G.D. SEARLE & CO. (US) | 1983-03-15 | — | — | US | claimed |
| US-4166113-A | POLYPEPTIDE | UNIVERSITY OF HAWAII (US) | 1979-08-28 | — | — | US | claimed |